Results of Allogeneic Bone Marrow Transplant in Chronic Myeloid Leukaemia Following Conditioning with Busulfan and Cyclophosphamide

Journal of Association of Physicians of India

Volumn 47, Issue 8, 1999, Pages 770-773

  Saikia, T K ^a   Advani, S H ^a   Parikh, P M ^a   Bapna, A ^a   Somjee, S ^a   Mukhopadhyay, A ^a   Gopal, R ^a   Nair, C N ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MORTALITY; MYELOID LEUKEMIA; SURVIVAL RATE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; BUSULFAN; CHILD; CYCLOPHOSPHAMIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; SURVIVAL RATE;

EID: 0033170720     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Goldman JM. Management of chronic myeloid leukaemia. Blood Reviews 1994; 8 : 21-9.
2. Bhatia R, Verfaule CM, Miller JS, McGlave PB. Autologous transplantation therapy for chronic myelogenous leukemia. Blood 1997; 89 : 2623-34.
3. Thomas ED, Clift RA, Fefer A, et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Int Med 1986; 104 : 155-63.
4. Goldman JM, Szydlo R, Horowitz MM, et al. Choice of pretransplant treatment and timing of transplant for chronic myelogenous leukemia in chronic phase. Blood 1993; 82 : 2235-8.
5. Biggs JC, Szer J, Crilley P, et al. Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2. Blood 1992; 80 : 1352-7.
6. Gratwohl A, Hermans J, Niederweiser D, Frassoni F, et al. Bone marrow transplantation for chronic myeloid leukemia : Long-term results. Chronic leukemia working party of the European group for bone marrow transplantation. Bone Marrow Transplant 1993; 12 : 509-16.
7. Clift RA, Buckner CD, Thomas ED, et al. Marrow transplantation for chronic myeloid leukemia : A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994; 84 : 2036-43.
8. Clift RA, Anasetti C. Allografting for chronic myeloid leukemia. Bailliere's Clinical Haematology : Chronic Myeloid Leukemia 1997; 10 : 319-36.
9. Petersdorf EW, Longton GM, Anasetti C, et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995; 86 : 1606-13.
10. Tutschka PJ, Copeland EA, Kapoor N. Replacing total body irradiation with busulfan as conditioning regimen of patients with leukemia for allogeneic transplantation. Transplantation 1989; 21 : 2952-4.
11. Saikia TK, Advani SH, Gopal R, et al. Preliminary experience with allogeneic bone marrow transplantation in haematologic disorders in India. J Assoc Physicians India 1990; 38 : 332-4.
12. Kelkar R, Sastry PSRK, Kulkarni SS, Saikia TK, Parikh PM, Advani SH. Pulmonary microsporodial infection in a patient with CML undergoing allogeneic marrow transplant. Bone Marrow Transplant 1997; 19 : 179-82.
13. Advani SH, Saikia TK. Bone marrow transplant in India. Bone Marrow Transplant 1994; 13 : 731-2.
14. Horowitz MM. New IBMTR/ABMTR slides summarize current use and outcome of allogeneic and autologous transplants. IBMTR Newsletter 1995; 2 : 7.
15. Slattery JT, Clift RA, Buckner CD, et al. Marrow transplantation for chronic myeloid leukemia : the influence of plasma busulfan levels on the outcome of transplantation. Blood 1997; 89 : 3055-60.
16. Goldman JM, Gale RP, Horowitz MM, et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase : Increased risk for relapse associated with T-cell depletion. Ann Int Med 1988; 108 : 806-14.
17. Hehlmann R, Kolb HJ, Berger U, Muth A, Hochhaus A, Ansari H. Influence of pretransplant treatment of survival after allogenous bone marrow transplantation in CML. Blood 1997; 90 (suppl 1) : 228a.
18. Morton AJ, Gooley T, Hansen JA, et al. Impact of pre-transplant interferon-alpha (IFN α) on outcome of unrelated donor marrow transplants for chronic myeloid leukemia (CML) in first chronic phase. Blood 1997; 90 (suppl 1) : 123a.